Health Abiomed will run as a stand-alone business within J&J's medical device segment once the deal is completed.Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots.The health care giant said Tuesday that it will buy the cardiovascular technology company Abiomed, which makes a heart pump used on patients with severe coronary artery disease.
#years #combination #massachusetts #temporarily #acquisition #bottom-line #pharmaceuticals #heart-disease #dow-jones-industrial-average
[
add
]
[
|
|
...
]